Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-25-000124
Filing Date
2025-05-21
Accepted
2025-05-21 16:50:20
Documents
1
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5252
  Complete submission text file 0001610717-25-000124.txt   6787
Mailing Address C/O AEON BIOPHARMA, INC. 4040 MACARTHUR BOULEVARD, SUITE 250 NEWPORT BEACH CA 92660
Business Address
FISCHER JOST (Reporting) CIK: 0001366841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40021 | Film No.: 25973733

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)